Hulse, Gary K.

Assessing motivation to quit smoking in people with mental illness: a review

Siru, R., Hulse, G. K., & Tait, R. J. (2009) · Addiction

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 301

Benzodiazepine dependence and its treatment with low dose flumazenil

Hood, S. D., Norman, A., Hince, D. A., Melichar, J. K., & Hulse, G. K. (2014) · British Journal of Clinical Pharmacology

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 165

Improving Clinical Outcomes in Treating Heroin Dependence: Randomized, Controlled Trial of Oral or Implant Naltrexone

Hulse, G. K., Morris, N., Arnold-Reed, D., & Tait, R. J. (2009) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 135

Effectiveness of a brief-intervention and continuity of care in enhancing attendance for treatment by adolescent substance users

Tait, R. J., Hulse, G. K., & Robertson, S. I. (2004) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 65

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone

Hulse, G. K., Ngo, H. T. T., & Tait, R. J. (2010) · Biological Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 37

Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: A case series

Hulse, G., O’Neil, G., Morris, N., Bennett, K., Norman, A., & Hood, S. (2013) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesPoisoning and overdose treatments

Cited by 27

A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept

MacDonald, T., Gallo, A. T., Basso-Hulse, G., Bennett, K. S., & Hulse, G. K. (2022) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 12

Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?

Gallo, A., MacDonald, T., Bennett, K., Basso-Hulse, G., & Hulse, G. (2022) · Journal of Clinical Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSubstance Abuse Treatment and Outcomes

Cited by 2